RheADC
1014.500.036 · rovalta.com · 07/11/2026
RheADC
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBORheADC is a Private limited company incorporated in 2024. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Leuven.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 1014.500.036
- Incorporation
- 02/10/2024
- Legal form
- Private limited company
- Registered office
- Ambachtenlaan 1
3001 Leuven · FlandreSee on map - Contributed capital
- 10 000,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 1 filingTrend over 1 financial year
| 2025 | |
|---|---|
| Income statement | |
| Gross margin | -116,2 k € |
| EBITDA | -116,2 k € |
| Operating result | -116,2 k € |
| Net result | -124,4 k € |
| Balance sheet | |
| Equity | -114,4 k € |
| Total assets | 31,4 k € |
| Cash | 11,4 k € |
| Debts | 138 k € |
Board of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Erwin Blomsma | Directorsince 01/10/2024 | ||
Katrien Reynders-Frederix | Directorsince 01/10/2024 |
Other companies at this address
Ambachtenlaan 1 3001 Leuven| Company | CBE no. |
|---|---|
Benno Therapeutics● Active | 1006.661.347 |
BIOHUB LEUVEN● Bankrupt | 0758.747.955 |
Tailored Lab Solutions Belgium● Active | 1034.130.262 |
Financials
Full financial information
Source · NBB| 2025 | |
|---|---|
| Type of account | Abridged model |
| Start of the financial year | 01/10/2024 |
| Closing of the financial year | 31/12/2025 |
| Length of the financial year | 15 months |
| Filing date | 11/06/2026 |
| General meeting | 04/06/2026 |
| Currency of the financial year | EUR |
| NBB quality label | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 1 filing| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 04/06/2026 | 11/06/2026 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Erwin Blomsma | Directorsince 01/10/2024 | ||
Katrien Reynders-Frederix | Directorsince 01/10/2024 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other04/10/2024RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Ambachtenlaan 1, 3001 HeverleeCurrent | accounts 2025 | Accounts 2025 · 2026-00153421 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| RheADCCurrent | accounts 2025 | Accounts 2025 · 2026-00153421 |
Events
- 2025Annual accounts 2025-124,4 k €
- 02/10/2024IncorporationPrivate limited company